Market Cap 62.40M
Revenue (ttm) 0.00
Net Income (ttm) -25.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.01
Volume 341,600
Avg Vol 466,766
Day's Range N/A - N/A
Shares Out 19.81M
Stochastic %K 43%
Beta 1.74
Analysts Strong Sell
Price Target $36.25

Company Profile

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-f...

Industry: Biotechnology
Sector: Healthcare
Phone: 484 254 6134
Address:
1201 Orange Street, Suite 600, Wilmington, United States
dontfeedthebashers
dontfeedthebashers Oct. 27 at 11:35 AM
0 · Reply
jonny80s
jonny80s Oct. 27 at 11:30 AM
$NRXP anyone have an answer as to why the volume is so heavy this morning?
1 · Reply
Ihavesunshineinmypocket
Ihavesunshineinmypocket Oct. 26 at 11:01 PM
$NRXP Here’s to a great week!
1 · Reply
psw_psw
psw_psw Oct. 26 at 9:46 PM
$NRXP tic tac tic tac ⏰ this one can double in the next 6 months.
0 · Reply
Ihavesunshineinmypocket
Ihavesunshineinmypocket Oct. 25 at 8:26 PM
0 · Reply
mary46
mary46 Oct. 25 at 7:16 PM
$NRXP need more big boyze buying
0 · Reply
dontfeedthebashers
dontfeedthebashers Oct. 25 at 5:46 PM
$NRXP People mistake silence for weakness, but this is precision. NRx isn’t stalling, they are calibrating. The board’s already set, and the next move may not even be theirs to make. The government is paving the road for approval, all we have to do now is cruise.
0 · Reply
Ihavesunshineinmypocket
Ihavesunshineinmypocket Oct. 25 at 4:29 PM
1 · Reply
Wirralboy
Wirralboy Oct. 25 at 2:49 PM
$NRXP http://Investing.com - H.C. Wainwright has reiterated its Buy rating and $40.00 price target on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), citing positive implications from a recent FDA approval for a competitor’s drug. According to InvestingPro data, NRXP has shown remarkable momentum with a 158% return over the past year, despite recent volatility. Analyst consensus remains strongly bullish, with price targets ranging from $25 to $46.
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 25 at 3:13 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $NRXP Current Share Price: $3.29 Contracts: $NRXP June 18, 2026 $8 Calls Scale in: $0.90- $1.09 Scale out: $1.39-$1.79 Can Easily Capture: 60% ROI Blended DTE: 238 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Latest News on NRXP
NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript

Aug 20, 2025, 12:23 PM EDT - 2 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q2 2025 Earnings Call Transcript


NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 10:50 AM EDT - 8 months ago

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript


dontfeedthebashers
dontfeedthebashers Oct. 27 at 11:35 AM
0 · Reply
jonny80s
jonny80s Oct. 27 at 11:30 AM
$NRXP anyone have an answer as to why the volume is so heavy this morning?
1 · Reply
Ihavesunshineinmypocket
Ihavesunshineinmypocket Oct. 26 at 11:01 PM
$NRXP Here’s to a great week!
1 · Reply
psw_psw
psw_psw Oct. 26 at 9:46 PM
$NRXP tic tac tic tac ⏰ this one can double in the next 6 months.
0 · Reply
Ihavesunshineinmypocket
Ihavesunshineinmypocket Oct. 25 at 8:26 PM
0 · Reply
mary46
mary46 Oct. 25 at 7:16 PM
$NRXP need more big boyze buying
0 · Reply
dontfeedthebashers
dontfeedthebashers Oct. 25 at 5:46 PM
$NRXP People mistake silence for weakness, but this is precision. NRx isn’t stalling, they are calibrating. The board’s already set, and the next move may not even be theirs to make. The government is paving the road for approval, all we have to do now is cruise.
0 · Reply
Ihavesunshineinmypocket
Ihavesunshineinmypocket Oct. 25 at 4:29 PM
1 · Reply
Wirralboy
Wirralboy Oct. 25 at 2:49 PM
$NRXP http://Investing.com - H.C. Wainwright has reiterated its Buy rating and $40.00 price target on NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), citing positive implications from a recent FDA approval for a competitor’s drug. According to InvestingPro data, NRXP has shown remarkable momentum with a 158% return over the past year, despite recent volatility. Analyst consensus remains strongly bullish, with price targets ranging from $25 to $46.
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Oct. 25 at 3:13 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $NRXP Current Share Price: $3.29 Contracts: $NRXP June 18, 2026 $8 Calls Scale in: $0.90- $1.09 Scale out: $1.39-$1.79 Can Easily Capture: 60% ROI Blended DTE: 238 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 24 at 7:35 PM
InvestorNewsBreaks – $NRXP Advancing Two-Pronged Approach to Bring Innovative Therapies to Market https://ibn.fm/s1eOw
0 · Reply
dontfeedthebashers
dontfeedthebashers Oct. 24 at 9:40 AM
$NRXP for those asking, "when will the run happen?"... 👀
3 · Reply
FounderV
FounderV Oct. 24 at 2:59 AM
$NRXP We will soon be able to dig countless pure gold...
0 · Reply
jonny80s
jonny80s Oct. 23 at 7:56 PM
$NRXP day trading pump and dump from now until we can get real investors onboard….. is what it looks like.
1 · Reply
Im_Trying
Im_Trying Oct. 23 at 6:15 PM
$NRXP when is the run?
3 · Reply
stocktowatchs
stocktowatchs Oct. 23 at 5:55 PM
NRx Pharmaceuticals ($NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies https://finance.yahoo.com/news/nrx-pharmaceuticals-nrxp-pursues-dual-190000916.html
0 · Reply
TheRealBomb
TheRealBomb Oct. 23 at 3:56 PM
$NRXP Bullish to the fullest! Really quiet here. Calm before the run. Longs are locked in and holding. Shorts are playing a dangerous game at this point. I'm looking forward to my shore side hammock on a Tuesday morning. More so, I'm excited for the near term movement of NRx that will directly translate into improving and saving lives!!!
0 · Reply
dontfeedthebashers
dontfeedthebashers Oct. 23 at 2:08 PM
$NRXP Bullish as always, bullish as ever
0 · Reply
Henry20feb_
Henry20feb_ Oct. 23 at 12:14 PM
$NRXP 'The KARMA-Dep 2 findings don’t invalidate NRx’s ketamine program but raise the evidentiary bar (to many differences in research design e.a.) NRX-100’s success will depend on proving a clinically meaningful, rapid anti-suicidal benefit in a well-defined population — not on broad antidepressant claims increasingly challenged by rigorous comparators.' (source comparison design: ChatGpt 23-10-2025)
0 · Reply
CURBOY
CURBOY Oct. 22 at 9:21 PM
$NRXP https://www.linkedin.com/posts/neuroscience-news_ketamine-fails-to-outperform-placebo-in-major-activity-7386827121324851200-zUnz?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAABVigSgBVBU_w9acPM-AwfHay98nhuonXiQ&utm_campaign=copy_link
3 · Reply
Ihavesunshineinmypocket
Ihavesunshineinmypocket Oct. 22 at 7:22 PM
0 · Reply
Ihavesunshineinmypocket
Ihavesunshineinmypocket Oct. 22 at 7:18 PM
0 · Reply